UVA Comprehensive Cancer Center
Virginia's first NCI comprehensive centre (2021), a leader in melanoma peptide vaccines and therapeutic focused ultrasound.
NCI-designated in 1987, UVA became Virginia's first comprehensive cancer centre in 2021 and serves Charlottesville and the Appalachian south-west of the state. Craig Slingluff's decades of melanoma peptide vaccine trials made UVA a reference site for cancer vaccine immunology, complemented by Timothy Bullock's T-cell work. UVA is one of the world's leading centres for therapeutic focused ultrasound, with the Focused Ultrasound Foundation based in Charlottesville and trials in tumour ablation and immune priming. Director Thomas Loughran is the leading authority on large granular lymphocytic leukaemia, and the centre has a busy transplant and haematology service.
- Melanoma vaccines
- Focused ultrasound
- Haematologic malignancies
Pages like this
not linked directly; found by shared links- TechnologySonodynamic therapy
Shares Insightec, Focused-ultrasound blood-brain barrier opening, Focused ultrasound & histotripsy.
- IdeaA standard platform to get drugs into the brain: focused ultrasound plus shuttle-engineered therapeutics
Shares Insightec, Focused ultrasound & histotripsy, Melanoma.
- CompanyHistoSonics
Shares Histotripsy as an immune primer, Focused ultrasound & histotripsy.
- InstitutionSunnybrook Odette Cancer Centre
Shares Insightec, Focused-ultrasound blood-brain barrier opening, Focused ultrasound & histotripsy.
- IdeaUltrasound-assisted blood test instead of a brain biopsy
Shares Insightec, Focused-ultrasound blood-brain barrier opening.
- IdeaOpen the barrier so engineered immune cells can enter the brain
Shares Insightec, Focused-ultrasound blood-brain barrier opening.
- IdeaDevice-agnostic public trials of ablation technologies against surgery
- IdeaVaccinate against the resistance mutation before it takes over
Shares Off-the-shelf cancer vaccines, No one can predict who responds to immunotherapy.